Publications

Results 1-61 of 61 (Search time: 0.007 seconds).

Issue DateTitleAuthor(s)TypescopusWOSFulltext/Archive link
12020Autophagy in fibroblasts induced by cigarette smoke extract promotes invasion in lung cancer cellsHou H.-H.; Pan H.-J.; WEI-YU LIAO ; Lee C.-H.; Yu C.-J.journal article00
22020Tubulointerstitial nephritis associated with erlotinib therapy for lung cancerCho S.-L.; Lin W.-C.; Chuang C.-A.; WEI-YU LIAO ; Lai C.-F.letter00
32020Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitorsYang C.-Y.; WEI-YU LIAO ; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.journal article22
42020Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving CrizotinibYang C.-Y.; WEI-YU LIAO ; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.journal article00
52020Exon 16–Skipping HER2 as a Novel Mechanism of Osimertinib Resistance in EGFR L858R/T790M–Positive Non–Small Cell Lung CancerHsu C.-C.; Liao B.-C.; WEI-YU LIAO ; Markovets A.; Stetson D.; Thress K.; Yang J.C.-H.journal article45
62019Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutationsLin Y.-T.; Chen J.-S.; WEI-YU LIAO ; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.journal article77
72019Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR InhibitorsLee J.-H.; Chen H.-Y.; Hsu F.-M.; Chen J.-S.; WEI-YU LIAO ; Shih J.-Y.; Yu C.-J.; Chen K.-Y.; Tsai T.-H.; Yang J.C.-H.journal article30
82019Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patientsYao Z.-H.; WEI-YU LIAO ; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.-H.; Yu C.-J.journal article45
92019Consecutive emergence of typical acquired resistance to EGFR tyrosine kinase inhibitors in a patient with metastatic pulmonary squamous cell carcinomaYang C.-Y.; Hsieh M.-S.; WEI-YU LIAO ; Shih J.-Y.; Yu C.-J.journal article00
102018Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use ProgramPeters S.; Curioni-Fontecedro A.; Nechushtan H.; Shih J.-Y.; WEI-YU LIAO ; Gautschi O.; Spataro V.; Unk M.; Chih-Hsin Yang J.; Lorence R.M.; Carri?re P.; Cseh A.; Chang G.-C.journal article2726
112018The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancerYu K.-L.; Tsai T.-H.; Ho C.-C.; WEI-YU LIAO ; Lin C.-K.; Hsu C.-L.; Shih J.-Y.journal article44
122018Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in TaiwanLin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; WEI-YU LIAO ; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.journal article1616
132018Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgeryYang W.-C.; Xiao F.; Shih J.-Y.; Ho C.-C.; Chen Y.-F.; Tseng H.-M.; Chen K.-Y.; WEI-YU LIAO ; Yu C.-J.; Yang J.C.-H.; Kuo S.-H.; Cheng J.C.-H.; Yang P.-C.; Hsu F.-M.journal article1010
142018Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic studyLin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; WEI-YU LIAO ; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.journal article4945
152018Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer PatientsWu T.-H.; Hsiue E.H.-C.; Lee J.-H.; Lin C.-C.; WEI-YU LIAO ; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.-H.journal article77
162018Trajectories of caregiver burden and related factors in family caregivers of patients with lung cancerLee Y.-H.; Liao Y.-C.; Shun S.-C.; Lin K.-C.; WEI-YU LIAO ; Chang P.-H.; Jhang S.-Y.; Yu C.-J.; Yang P.-C.; Hsieh P.-Y.; Lai Y.-H.journal article43
172018Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinumWEI-YU LIAO ; Ho C.-C.; Tsai T.-H.; Chen K.-Y.; Shih J.-Y.; Yu C.-J.journal article34
182018Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort studyLiang S.-K.; Lee M.-R.; WEI-YU LIAO ; Ho C.-C.; Ko J.-C.; Shih J.-Y.journal article80
192018Psychological distress and coping strategies among women with incurable lung cancer: a qualitative studyLiao Y.-C.; WEI-YU LIAO ; Sun J.-L.; Ko J.-C.; Yu C.-J.journal article52
202018Cigarette smoke extract enhances the invasion of lung cancer cells co-cultured with fibroblasts in 3D cellular spheroidsPan H.-J.; Hou H.-H.; Hung Y.-C.; WEI-YU LIAO ; Yu C.-J.; Lee C.-H.conference paper0
212017Predictive factors for EGFR-tyrosine kinase inhibitor retreatment in patients with EGFR-mutated non-small-cell lung cancer – A multicenter retrospective SEQUENCE studyChang G.-C.; Tseng C.-H.; Hsu K.-H.; Yu C.-J.; Yang C.-T.; Chen K.-C.; Yang T.-Y.; Tseng J.-S.; Liu C.-Y.; WEI-YU LIAO ; Hsia T.-C.; Tu C.-Y.; Lin M.-C.; Tsai Y.-H.; Hsieh M.-J.; Wu W.-S.; Chen Y.-M.journal article1411
222017Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinibYao Z.-H.; WEI-YU LIAO ; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.H.; Yu C.-J.journal article1110
232017Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with OsimertinibHo C.-C.; WEI-YU LIAO ; Lin C.-A.; Shih J.-Y.; Yu C.-J.; Chih-Hsin Yang J.journal article8779
242016Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysisChen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; WEI-YU LIAO ; Yu K.-L.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C.journal article4139
252016Prospective evaluation of procalcitonin, soluble triggering receptor expressed on myeloid cells-1 and c-reactive protein in febrile patients with autoimmune diseasesLin C.-H.; Hsieh S.-C.; Keng L.-T.; Lee H.-S.; Chang H.-T.; WEI-YU LIAO ; Ho C.-C.; Yu C.-J.journal article65
262016The unmet supportive care needs—what advanced lung cancer patients’ caregivers need and related factorsChen S.-C.; Chiou S.-C.; Yu C.-J.; Lee Y.-H.; WEI-YU LIAO ; Hsieh P.-Y.; Jhang S.-Y.; Lai Y.-H.journal article2627
272015Identification of Five Driver Gene Mutations in Patients with Treatment-Na?ve Lung Adenocarcinoma in TaiwanHsu K.-H.; Ho C.-C.; Hsia T.-C.; Tseng J.-S.; Su K.-Y.; Wu M.-F.; Chiu K.-L.; Yang T.-Y.; Chen K.-C.; Ooi H.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; WEI-YU LIAO ; Shih J.-Y.; Yu S.-L.; Yu C.-J.; Yang P.-C.; Chang G.-C.journal article4242
282015EGFR mutation and lobar location of lung adenocarcinomaTseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Ho C.-C.; Hsia T.-C.; Su K.-Y.; Wu M.-F.; Chiu K.-L.; Liu C.-M.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; WEI-YU LIAO ; Shih J.-Y.; Yu S.-L.; Yu C.-J.; Yang P.-C.; Yang T.-Y.; Chang G.-C.journal article44
292015Discordant HER2 Exon 20 mutation status determines a differential sensitivity to AfatinibGow C.-H.; WEI-YU LIAO ; Liu Y.-N.; Shih J.-Y.journal article98
302015Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancerWEI-YU LIAO ; Ho C.-C.; Hou H.-H.; Hsu T.-H.; Tsai M.-F.; Chen K.-Y.; Chen H.-Y.; Lee Y.-C.; Yu C.-J.; Lee C.-H.; Yang P.-C.journal article1313
312015GM2-activator protein: A new biomarker for lung cancerPotprommanee L.; Ma H.-T.; Shank L.; Juan Y.-H.; WEI-YU LIAO ; Chen S.-T.; Yu C.-J.journal article76
322014Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemona?ve patients with EGFR-mutant lung adenocarcinomaTseng J.-S.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Yu C.-J.; WEI-YU LIAO ; Tsai C.-R.; Tsai M.-H.; Yu S.-L.; Su K.-Y.; Chen J.J.W.; Chen H.-Y.; Chang G.-C.journal article1413
332014Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancerLee J.-H.; Lin Y.-L.; Hsu W.-H.; Chen H.-Y.; Chang Y.-C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Chen K.-Y.; Ho C.-C.; WEI-YU LIAO ; Yang P.-C.; Yang J.C.-H.journal article3832
342014Modulating chemotaxis of lung cancer cells by using electric fields in a microfluidic deviceKao Y.-C.; Hsieh M.-H.; Liu C.-C.; Pan H.-J.; WEI-YU LIAO ; Cheng J.-Y.; Kuo P.-L.; Lee C.-H.journal article1313
352014Quality of life and related factors in patients with newly diagnosed advanced lung cancer: A longitudinal studyLiao Y.-C.; Shun S.-C.; WEI-YU LIAO ; Yu C.-J.; Yang P.-C.; Lai Y.-H.journal article300
362013Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopyTsai T.-H.; Yang C.-Y.; Ho C.-C.; WEI-YU LIAO ; Jan I.-S.; Chen K.-Y.; Wang J.-Y.; Ruan S.-Y.; Yu C.-J.; Yang J.C.H.; Yang P.-C.; Shih J.-Y.journal article2829
372013Anxiety, depression and related factors in family caregivers of newly diagnosed lung cancer patients before first treatmentLee Y.-H.; Liao Y.-C.; WEI-YU LIAO ; Shun S.-C.; Liu Y.-C.; Chan J.-C.; Yu C.-J.; Yang P.-C.; Lai Y.-H.journal article2519
382013Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancerWEI-YU LIAO ; Chen J.-H.; Wu M.; Shih J.-Y.; Chen K.-Y.; Ho C.-C.; Yang J.C.-H.; Yu C.-J.journal article1412
392013Interaction between lung cancer cell and myofibroblast influenced by cyclic tensile strainHuang J.-W.; Pan H.-J.; Yao W.-Y.; Tsao Y.-W.; WEI-YU LIAO ; Wu C.-W.; Tung Y.-C.; Lee C.-H.journal article1112
402013Survival of lung adenocarcinoma patients with malignant pleural effusionWu S.-G.; Yu C.-J.; Tsai M.-F.; WEI-YU LIAO ; Yang C.-H.; Jan I.-S.; Yang P.-C.; Shih J.-Y.journal article6052
412012Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinumWEI-YU LIAO ; Shih J.-Y.; Chang G.-C.; Cheng Y.-K.; Yang J.C.-H.; Chen Y.-M.; Yu C.-J.journal article4547
422012Risk Factors of Pneumothorax after Endobronchial Ultrasound-Guided Transbronchial Biopsy for Peripheral Lung LesionsHuang C.-T.; Ruan S.-Y.; WEI-YU LIAO ; Kuo Y.-W.; Lin C.-Y.; Tsai Y.-J.; Ho C.-C.; Yu C.-J.journal article1918
432012The migration speed of cancer cells influenced by macrophages and myofibroblasts co-cultured in a microfluidic chipHsu T.-H.; Kao Y.-L.; Lin W.-L.; Xiao J.-L.; Kuo P.-L.; Wu C.-W.; WEI-YU LIAO ; Lee C.-H.journal article2425
442012Endobronchial ultrasound-guided transbronchial biopsy of peripheral pulmonary lesions: How many specimens are necessary?Huang C.-T.; Tsai Y.-J.; WEI-YU LIAO ; Wu P.-C.; Ho C.-C.; Yu C.-J.; Yang P.-C.journal article1818
452011Analysis of the paracrine loop between cancer cells and fibroblasts using a microfluidic chipHsu T.-H.; Xiao J.-L.; Tsao Y.-W.; Kao Y.-L.; Huang S.-H.; WEI-YU LIAO ; Lee C.-H.journal article3637
462011Symptoms, psychological distress, and supportive care needs in lung cancer patientsLiao Y.-C.; WEI-YU LIAO ; Shun S.-C.; Yu C.-J.; Yang P.-C.; Lai Y.-H.journal article4949
472011Using a three-chamber culture chip to study the interactions among cancer cells and two types of stromal cellsLee C.-H.; Hsu T.-H.; Kao Y.-L.; Lin W.-L.; WEI-YU LIAO conference paper0
482009Label-free quantification of asymmetric cancer-cell filopodium activities in a multi-gradient chipHsu T.-H.; Yen M.-H.; WEI-YU LIAO ; Cheng J.-Y.; Lee C.-H.journal article109
492009Emphysematous gastritis: A deadly infectious diseaseHuang C.-T.; WEI-YU LIAO journal article1615
502008TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancerHo C.-C.; WEI-YU LIAO ; Wang C.-Y.; Lu Y.-H.; Huang H.-Y.; Chen H.-Y.; Chan W.-K.; Chen H.-W.; Yang P.-C.journal article8881
512007Dynamics of cancer cell filopodia characterized by super-resolution bright-field optical microscopyHsu T.-H.; WEI-YU LIAO ; Yang P.-C.; Wang C.-C.; Xiao J.-L.; Lee C.-H.journal article98
522007Cancer cell filopodia characterized by super-resolution bright-field optical microscopyLee C.-H.; Hsu T.-H.; WEI-YU LIAO ; Yang P.-C.; Wang C.-C.; Xiao J.-L.conference paper00
532007Cancer cell filopodia characterized by super-resolution bright-field optical microscopyLee C.-H.; Hsu T.-H.; WEI-YU LIAO ; Yang P.-C.; Wang C.-C.; Xiao J.-L.conference paper0
542005Global expression profiling of theophylline response genes in macrophages: Evidence of airway anti-inflammatory regulationYao P.-L.; Tsai M.-F.; Lin Y.-C.; Wang C.-H.; WEI-YU LIAO ; Chen J.J.W.; Yang P.-C.journal article2220
552005Autocrine and paracrine regulation of interleukin-8 expression in lung cancer cellsYao P.-L.; Lin Y.-C.; Wang C.-H.; Huang Y.-C.; WEI-YU LIAO ; Wang S.-S.; Chen J.J.W.; Yang P.-C.journal article3633
562004Value of imprint cytology for ultrasound-guided transthoracic core biopsyWEI-YU LIAO ; Jerng J.-S.; Chen K.-Y.; Chang Y.-L.; Yang P.-C.; Kuo S.-H.journal article1715
572004The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasmsChang Y.-L.; Lee Y.-C.; WEI-YU LIAO ; Wu C.-T.journal article7857
582004Testing the functional status model in patients with chronic obstructive pulmonary diseaseYeh M.-L.; Chen H.-H.; Liao Y.-C.; WEI-YU LIAO journal article2622
592002Pneumothorax in the ICU: Patient outcomes and prognostic factorsChen K.-Y.; Jerng J.-S.; WEI-YU LIAO ; Ding L.-W.; Kuo L.-C.; Wang J.-Y.; Yang P.-C.journal article3944
602000US-guided transthoracic cutting biopsy for peripheral thoracic lesions less than 3 cm in diameterWEI-YU LIAO ; Chen M.-Z.; Chang Y.-L.; Wu H.-D.; Yu C.-J.; Kuo P.-H.; Yang P.-C.journal article6458
612000Bacteriology of infected cavitating lung tumorWEI-YU LIAO ; Liaw Y.-S.; Wang H.-C.; Chen K.-Y.; Luh K.-T.; Yang P.-C.journal article3228